Pneumonia Research Today is a free monthly online journal that collates and summarizes the latest research about Pneumonia, including details on symptoms, viral, bacterial, treatment, causes, walking pneumonia.

Volume 2 (2005), Issue 8 (August)

1. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma.
   Biochem Biophys Res Commun, 334(4): 1141-8. [Abstract] [Full-text]
2. Applicability of prediction rules in patients with community-acquired pneumonia requiring intensive care: a pilot study.
   J Intensive Care Med, 20(4): 226-32. [Abstract] [Full-text]
3. Genotypic variation in Pneumocystis jirovecii isolates in Britain.
   Thorax, 60(8): 679-82. [Abstract] [Full-text]
4. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
   Thorax, 60(8): 672-8. [Abstract] [Full-text]
5. RU486 blocks the anti-inflammatory effects of exercise in a murine model of allergen-induced pulmonary inflammation.
   Brain Behav Immun, 19(5): 413-22. [Abstract] [Full-text]
6. Swine and poultry pathogens: the complete genome sequences of two strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae.
   J Bacteriol, 187(16): 5568-77. [Abstract] [Full-text]
7. Influenza and pneumonia in pregnancy.
   Clin Perinatol, 32(3): 727-38. [Abstract] [Full-text]
8. MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia.
   J Biol Chem, 280(32): 29242-9. [Abstract] [Full-text]
9. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease.
   Semin Respir Crit Care Med, 26(2): 192-203. [Abstract] [Full-text]
10. Total antioxidant status and severity of community-acquired pneumonia: are they correlated?
    Respiration, 72(4): 381-7. [Abstract] [Full-text]
11. Multilevel and continuous pleural fluid pH likelihood ratios for draining parapneumonic effusions.
    Respiration, 72(4): 351-6. [Abstract] [Full-text]
12. Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae.
    Pediatr Neurol, 33(2): 105-9. [Abstract] [Full-text]
13. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.
    Infection, 33(4): 257-63. [Abstract] [Full-text]
14. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation.
    Am J Physiol Lung Cell Mol Physiol, 289(3): L478-88. [Abstract] [Full-text]
15. Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types.
    Am J Physiol Lung Cell Mol Physiol, 289(3): L382-90. [Abstract] [Full-text]
16. Mycoplasma pneumoniae infection in children with acute respiratory infection.
    J Trop Pediatr, 51(4): 232-5. [Abstract] [Full-text]
17. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia.
    Chest, 128(2): 940-6. [Abstract] [Full-text]
18. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features.
    Chest, 128(2): 573-9. [Abstract] [Full-text]
19. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia.
    Chest, 128(2): 545-52. [Abstract] [Full-text]
20. Contribution of blinded, protected quantitative specimens to the diagnostic and therapeutic management of ventilator-associated pneumonia.
    Chest, 128(2): 533-44. [Abstract] [Full-text]
21. Mycoplasma pneumoniae and central nervous system complications: a review.
    J Lab Clin Med, 146(2): 55-63. [Abstract] [Full-text]
22. Suppression of Th2 immune responses by mekabu fucoidan from Undaria pinnatifida sporophylls.
    Int Arch Allergy Immunol, 137(4): 289-94. [Abstract] [Full-text]
23. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Clin Microbiol Infect, 11(9): 690-703. [Abstract] [Full-text]
24. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles.
    Am J Respir Cell Mol Biol, 33(3): 290-6. [Abstract] [Full-text]
25. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation.
    Am J Respir Cell Mol Biol, 33(3): 248-53. [Abstract] [Full-text]
26. Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival.
    J Am Geriatr Soc, 53(7): 1108-16. [Abstract] [Full-text]
27. Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.
    Chemotherapy, 51(4): 186-92. [Abstract] [Full-text]
28. Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.
    Brain Dev, 27(6): 431-3. [Abstract] [Full-text]
29. Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults.
    Int J Infect Dis, 9(5): 274-9. [Abstract] [Full-text]
30. Signs and symptoms indicative of community-acquired pneumonia in infants under six months.
    Braz J Infect Dis, 9(2): 150-5. [Abstract] [Full-text]
31. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia.
    Scand J Infect Dis, 37(9): 657-63. [Abstract] [Full-text]
32. Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period.
    Surg Infect (Larchmt), 6(2): 203-13. [Abstract] [Full-text]
33. New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment.
    J Infect Chemother, 11(4): 182-8. [Abstract] [Full-text]
34. Respiratory pathogens in dental plaque of hospitalized patients with chronic lung diseases.
    Clin Oral Investig, 9(3): 141-7. [Abstract] [Full-text]

© 2004-2008 Pneumonia Research Today. All Rights Reserved.